(Fighting New Coronary Pneumonia) Germany's new diagnoses rebounded sharply in a single day, the disease control agency warned that the country has entered the third wave of epidemics

  China News Agency, Berlin, March 11 (Reporter Peng Dawei) The number of newly diagnosed new crown virus infections in Germany in a single day has stabilized below 10,000 for several consecutive days, and rebounded sharply to 14,356 on the 11th.

Willer, director of the Robert Koch Institute, a German disease control agency, warned on the same day that the existing signs clearly show that Germany has begun to enter the third wave of epidemics.

  The Robert Koch Institute announced the new death toll that day was 321.

According to real-time data from Germany's "Times Online", as of 20:20 on the 11th local time, Germany had a total of 2,546,776 confirmed diagnoses, 2,336,566 cured, and 73,647 deaths.

According to the vaccination data of the German Ministry of Health, as of that day, Germany had received 8,431264 doses of vaccine, of which 2,674,692 had received the second dose.

  Willer made the above remarks during a dialogue with members of the United Nations Geneva Correspondents Association that day.

  Willer said he is very worried about the development of the epidemic in Germany.

He emphasized that although large-scale vaccination has been implemented, it is still extremely necessary to adhere to the epidemic prevention measures such as wearing masks and maintaining interpersonal distance.

  Willer said that vaccination is a race against the mutation of the new crown virus for time.

He said that people can already see the finish line of this race. If there is no interruption in vaccine production or other accidents, 80% of the population in Germany will be immune by this fall.

  "If the above situation can be achieved, then all epidemic prevention measures can be revoked." Willer said.

  At present, good news is beginning to spread in Germany regarding vaccination.

On the same day, the European Medicines Agency approved the new crown vaccine developed by Johnson & Johnson of the United States.

Pfizer also said that the actual output of the new crown vaccine jointly developed by it and Germany's BioNTech this year will exceed the original plan by 20%, reaching 2.3 billion to 2.4 billion doses.

  On the same day, the German Minister of Health Span predicted that the Johnson & Johnson vaccine could be used in EU countries as early as mid-April.

(Finish)